drugset / Trial / NCT05546060
Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to investigate the efficacy and safety of venetoclax combined with dexamethasone and etoposide as a salvage therapy for hemophagocytic lymphohistiocytosis.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2025-07-01
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 1.25 mg/m2 | — |
| Subject | Etoposide | Small molecule | 75 mg/m2 | — |
| Subject | Venetoclax | Small molecule | 400 mg | — |